Furthermore, treatment of NSCLC cells and LC PDOs with TAT-1/6i reduced arginine methylation of ILF2 (Figure 6F) indicating that PRMT1/PRMT6 heteromer is responsible for ILF2 methylation. Here, PRMT6 is linked to non-small cell lung carcinoma.